Scientific Staff
Andrew Cherniack, PhD
Group Leader, Computational Biology
2010-
PhD, The Ohio State University
I coordinate analysis of somatic copy number alterations for the Cancer Genome Atlas and other projects. I am also focused on mining cancer genomic data for new oncology targets.
http://www.aacc.org/publications/cln/2013/august/Pages/Endometrial-Cancer.aspx
617-714-8549
Email Dr. Cherniack
Group Leader, Computational Biology
2010-
PhD, The Ohio State University
I coordinate analysis of somatic copy number alterations for the Cancer Genome Atlas and other projects. I am also focused on mining cancer genomic data for new oncology targets.
http://www.aacc.org/publications/cln/2013/august/Pages/Endometrial-Cancer.aspx
617-714-8549
Email Dr. Cherniack
Jon Goldstein, PhD
Research Scientist II
2014-
PhD, University of Wisconsin - Madison
My focus is to understand the biochemical and cellular consequences of genomic alterations in cancer. My goal is to translate these findings into targeted therapeutic candidates.
LinkedIn: https://www.linkedin.com/in/jtgoldstein
617-714-7574
Email Dr. Goldstein
Research Scientist II
2014-
PhD, University of Wisconsin - Madison
My focus is to understand the biochemical and cellular consequences of genomic alterations in cancer. My goal is to translate these findings into targeted therapeutic candidates.
LinkedIn: https://www.linkedin.com/in/jtgoldstein
617-714-7574
Email Dr. Goldstein
Heidi Greulich, PhD
Lead Scientist/Group Leader
2004-
PhD, The Rockefeller University
I study the functional consequences of genomic lesions observed in cancer, using molecular and cellular approaches to experimentally evaluate relevance to tumorigenesis.
LinkedIn: https://www.linkedin.com/in/heidigreulich
617-714-7475
Email Dr. Greulich
Lead Scientist/Group Leader
2004-
PhD, The Rockefeller University
I study the functional consequences of genomic lesions observed in cancer, using molecular and cellular approaches to experimentally evaluate relevance to tumorigenesis.
LinkedIn: https://www.linkedin.com/in/heidigreulich
617-714-7475
Email Dr. Greulich
Aruna Ramachandran, PhD
Senior Scientist
2014-
PhD, National Institute of Immunology, India
I collaborate with the principal investigator to facilitate the laboratory’s research programs and scientific communications, including development of research proposals and manuscripts, and assist with scientific strategy and financial planning.
My goal is to enhance the lab's creative and intellectual growth.
“You must be the change you wish to see in the world.” — Mahatma Gandhi
LinkedIn: www.linkedin.com/in/raruna/
617-632-4775
Email Dr. Ramachandran
Senior Scientist
2014-
PhD, National Institute of Immunology, India
I collaborate with the principal investigator to facilitate the laboratory’s research programs and scientific communications, including development of research proposals and manuscripts, and assist with scientific strategy and financial planning.
My goal is to enhance the lab's creative and intellectual growth.
“You must be the change you wish to see in the world.” — Mahatma Gandhi
LinkedIn: www.linkedin.com/in/raruna/
617-632-4775
Email Dr. Ramachandran
Craig Strathdee, PhD
Senior Group Leader
2013-
PhD, University of Guelph, Canada
My research centers on oncology drug discovery, with a focus on the development and implementation of cell-based technology platforms in target validation and assay development experiments.
LinkedIn: https://www.linkedin.com/in/strathdee
617-714-7579
Email Dr. Strathdee
Senior Group Leader
2013-
PhD, University of Guelph, Canada
My research centers on oncology drug discovery, with a focus on the development and implementation of cell-based technology platforms in target validation and assay development experiments.
LinkedIn: https://www.linkedin.com/in/strathdee
617-714-7579
Email Dr. Strathdee
Junior Scientific Staff
Bethany Kaplan, BS, MS
Lead Research Technician
2010-
BS, MS, Brandeis University
I conduct functional assays of somatic mutations identified by the sequencing of human tumors to determine which mutations play a role in tumorigenesis. Right now, I am working on ERBB2, a receptor tyrosine kinase gene found to be frequently mutated in glioblastoma.
617-714-7566
Email Ms. Kaplan
Lead Research Technician
2010-
BS, MS, Brandeis University
I conduct functional assays of somatic mutations identified by the sequencing of human tumors to determine which mutations play a role in tumorigenesis. Right now, I am working on ERBB2, a receptor tyrosine kinase gene found to be frequently mutated in glioblastoma.
617-714-7566
Email Ms. Kaplan